Teva Pharmaceutical Industries Ltd

Latest stories

2d
Investopedia
3 Large-Cap Value Mutual Funds for Bull and Bear Markets (MLVEX, FBCVX)holding at 25.9%, followed by technology with 21.51% and health care at 16.11%.
3 Large-Cap Value Mutual Funds for Bull and Bear Markets (MLVEX, FBCVX)
Investopedia / Posted 2 days ago
holding at 25.9%, followed by technology with 21.51% and health care at 16.11%. The largest positions in the portfolio are Teva Pharmaceutical Industries Ltd ADR (NYSE: TEVA) with 4.42%, EMC Corporation (NYSE: EMC) at 4.1% and JPMorgan Chase & Co.... Read more
4d
FOX Business
Mylan, Allergan Shares Fall After Perrigo Profit Warningothers in the generic drug business, Endo International PLC's stock dropped 2.9
Mylan, Allergan Shares Fall After Perrigo Profit Warning
FOX Business / Posted 4 days ago
others in the generic drug business, Endo International PLC's stock dropped 2.9% and Mallinckrodt PLC's fell 2.1%, while Teva Pharmaceutical Industries Ltd.'s eased 0.1%. Meanwhile, Evercore ISI analyst Umer Raffat said he didn't see much of an... Read more
4d
FOX Business
Mylan, Allergan Shares Fall After Perrigo Profit Warningothers in the generic drug business, Endo International PLC's stock dropped 2.9
Mylan, Allergan Shares Fall After Perrigo Profit Warning
FOX Business / Posted 4 days ago
others in the generic drug business, Endo International PLC's stock dropped 2.9% and Mallinckrodt PLC's fell 2.1%, while Teva Pharmaceutical Industries Ltd.'s eased 0.1%. Meanwhile, Evercore ISI analyst Umer Raffat said he didn't see much of an... Read more
23d
Crain's New York Business
Uninverted: Pfizer and Allergan walk away from $160 billion merger under new tax rulesanalyst Elizabeth Krutoholow in an e-mail. Allergan will likely go ahead with
Uninverted: Pfizer and Allergan walk away from $160 billion merger under new tax rules
Crain's New York Business / Posted 23 days ago
analyst Elizabeth Krutoholow in an e-mail. Allergan will likely go ahead with a deal to sell its generics business to Teva Pharmaceutical Industries Ltd., which will give it about $33 billion in cash, allowing it to pay down debt or pursue... Read more
706 related stories
23d
FOX Business
Pfizer Drops Allergan Takeoverextensive planning for a combination, with Allergan more focused on completing
Pfizer Drops Allergan Takeover
FOX Business / Posted 23 days ago
extensive planning for a combination, with Allergan more focused on completing a deal to sell its generic drugs business to Teva Pharmaceutical Industries Ltd., according to one of the people familiar with the situation. If the Teva deal is... Read more
706 related stories
23d
FOX Business
Pfizer Drops Allergan Takeoverextensive planning for a combination, with Allergan more focused on completing
Pfizer Drops Allergan Takeover
FOX Business / Posted 23 days ago
extensive planning for a combination, with Allergan more focused on completing a deal to sell its generic drugs business to Teva Pharmaceutical Industries Ltd., according to one of the people familiar with the situation. If the Teva deal is... Read more
706 related stories
24d
Newsmax
Drug Makers Double Prices on Many Common Drugswhich raised the price of arthritis drug Humira more than 126 percent, Reuters
Drug Makers Double Prices on Many Common Drugs
Newsmax / Posted 24 days ago
which raised the price of arthritis drug Humira more than 126 percent, Reuters found. Next were Amgen Inc (AMGN.O) and Teva Pharmaceutical Industries Ltd (TEVA.TA), which raised prices for arthritis treatment Enbrel and multiple sclerosis drug... Read more
10 related stories
24d
FOX News
Drug makers took big price increases on widely used US drugswhich raised the price of arthritis drug Humira more than 126 percent, Reuters
Drug makers took big price increases on widely used US drugs
FOX News / Posted 24 days ago
which raised the price of arthritis drug Humira more than 126 percent, Reuters found. Next were Amgen Inc (AMGN.O) and Teva Pharmaceutical Industries Ltd (TEVA.TA), which raised prices for arthritis treatment Enbrel and multiple sclerosis drug... Read more
10 related stories
24d
Times of Malta
Makers took price increase on widely used US medicinesAbbVie Inc, which raised the price of arthritis drug Humira more than 126 per c
Makers took price increase on widely used US medicines
Times of Malta / Posted 24 days ago
AbbVie Inc, which raised the price of arthritis drug Humira more than 126 per cent, Reuters found. Next were Amgen Inc and Teva Pharmaceutical Industries Ltd, which raised prices for arthritis treatment Enbrel and multiple sclerosis drug Copaxone... Read more
10 related stories
24d
TribLIVE
Drug companies defend steep price hikes on top medicationsAbbVie Inc., which raised the price of arthritis drug Humira more than 126 perc
Drug companies defend steep price hikes on top medications
TribLIVE / Posted 24 days ago
AbbVie Inc., which raised the price of arthritis drug Humira more than 126 percent, Reuters found. Next were Amgen Inc. and Teva Pharmaceutical Industries Ltd., which raised prices for arthritis treatment Enbrel and multiple sclerosis drug Copaxone... Read more
10 related stories
24d
KWWL Iowa
Drug companies boosted their prices, analysis findwas AbbVie Inc., which raised the price of arthritis drug Humira more than 126
Drug companies boosted their prices, analysis find
KWWL Iowa / Posted 24 days ago
was AbbVie Inc., which raised the price of arthritis drug Humira more than 126 percent, Reuters found. Next were Amgen and Teva Pharmaceutical Industries Ltd., which raised prices for arthritis treatment Enbrel and multiple sclerosis drug Copaxone... Read more
10 related stories
24d
Business Insurance
Makers took big price increases on widely used U.S. drugswas AbbVie Inc., which raised the price of arthritis drug Humira more than 126%
Makers took big price increases on widely used U.S. drugs
Business Insurance / Posted 24 days ago
was AbbVie Inc., which raised the price of arthritis drug Humira more than 126%, Reuters found. Next were Amgen Inc. and Teva Pharmaceutical Industries Ltd., which raised prices for arthritis treatment Enbrel and multiple sclerosis drug Copaxone... Read more
10 related stories
25d
NBC News
Drug Companies Boosted Their Prices, Analysis Findswas AbbVie Inc., which raised the price of arthritis drug Humira more than 126
Drug Companies Boosted Their Prices, Analysis Finds
NBC News / Posted 25 days ago
was AbbVie Inc., which raised the price of arthritis drug Humira more than 126 percent, Reuters found. Next were Amgen and Teva Pharmaceutical Industries Ltd., which raised prices for arthritis treatment Enbrel and multiple sclerosis drug Copaxone... Read more
10 related stories
25d
Reuters
Makers took big price increases on widely used U.S. drugswhich raised the price of arthritis drug Humira more than 126 percent, Reuters
Makers took big price increases on widely used U.S. drugs
Reuters / Posted 25 days ago
which raised the price of arthritis drug Humira more than 126 percent, Reuters found. Next were Amgen Inc (AMGN.O) and Teva Pharmaceutical Industries Ltd (TEVA.TA), which raised prices for arthritis treatment Enbrel and multiple sclerosis drug... Read more
10 related stories
25d
The Economic Times
Makers took big price increases on widely used U.S. drugsAbbVie Inc, which raised the price of arthritis drug Humira more than 126 perce
Makers took big price increases on widely used U.S. drugs
The Economic Times / Posted 25 days ago
AbbVie Inc, which raised the price of arthritis drug Humira more than 126 percent, Reuters found. Next were Amgen Inc and Teva Pharmaceutical Industries Ltd, which raised prices for arthritis treatment Enbrel and multiple sclerosis drug Copaxone... Read more
10 related stories
25d
Channel NewsAsia
Makers took big price increases on widely used US drugsAbbVie Inc, which raised the price of arthritis drug Humira more than 126 perce
Makers took big price increases on widely used US drugs
Channel NewsAsia / Posted 25 days ago
AbbVie Inc, which raised the price of arthritis drug Humira more than 126 percent, Reuters found. Next were Amgen Inc and Teva Pharmaceutical Industries Ltd, which raised prices for arthritis treatment Enbrel and multiple sclerosis drug Copaxone... Read more
10 related stories
28d
Business Wire
Takeda and Teva Establish “Teva Takeda Yakuhin Ltd.” in JapanJERUSALEM & OSAKA, Japan--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd.
Takeda and Teva Establish “Teva Takeda Yakuhin Ltd.” in Japan
Business Wire / Posted 28 days ago
JERUSALEM & OSAKA, Japan--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and Takeda Pharmaceutical Company Limited (TSE:4502) announce the establishment of Teva Takeda Yakuhin Ltd. (“Teva Takeda Yakuhin”). The newly... Read more
2 related stories
29d
FOX News
FDA: New 'Morning-After' Pill Effective, Safedrug is more akin to the abortion pill, sold by Danco Laboratories as Mifeprex
FDA: New 'Morning-After' Pill Effective, Safe
FOX News / Posted 29 days ago
drug is more akin to the abortion pill, sold by Danco Laboratories as Mifeprex and also known as RU-486 or mifepristone. Teva Pharmaceutical Industries Ltd sells a rival product, called Plan B, a two-pill regimen with generic competition from... Read more
1m
The Seattle Times
Alder shares surge on test results for migraine treatmentMay 2014, was up 46.3 percent to $25.11 at 9:15 a.m. PST. The results help Ald
Alder shares surge on test results for migraine treatment
The Seattle Times / Posted a month ago
May 2014, was up 46.3 percent to $25.11 at 9:15 a.m. PST. The results help Alder keep pace in a tight race withdrugmakers Teva Pharmaceutical Industries Ltd., Amgen Inc., Eli Lilly & Co. and Allergan Plc that are looking to get migraines therapies... Read more
4 related stories
m
Channel NewsAsia
Alder drug to prevent migraines successful in mid-stage studywho use them, the American Migraine Foundation estimates. Alder joins companie
Alder drug to prevent migraines successful in mid-stage study
Channel NewsAsia / Posted 1 months ago
who use them, the American Migraine Foundation estimates. Alder joins companies such as Amgen Inc, Eli Lilly Co and Teva Pharmaceutical Industries Ltd that are developing similar drugs to target calcitonin gene-related peptide, or CGRP, a... Read more
4 related stories

People in this news